Peng Zhang

11.7k total citations · 4 hit papers
196 papers, 5.3k citations indexed

About

Peng Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Peng Zhang has authored 196 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 85 papers in Oncology and 70 papers in Molecular Biology. Recurrent topics in Peng Zhang's work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (30 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Peng Zhang is often cited by papers focused on Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (30 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Peng Zhang collaborates with scholars based in China, United States and Australia. Peng Zhang's co-authors include Xin Zhang, Wang Xinzhou, Qian Chu, Gening Jiang, Liangdong Sun, Yu Deng, Yilv Yan, Chenfei Wang, Ya Han and Jin Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peng Zhang

183 papers receiving 5.2k citations

Hit Papers

TISCH: a comprehensive web resource enabling interactive ... 2020 2026 2022 2024 2020 2021 2023 2025 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Zhang China 38 2.4k 1.7k 1.5k 946 916 196 5.3k
Mingxing Li China 40 2.6k 1.1× 819 0.5× 917 0.6× 1.1k 1.2× 700 0.8× 192 5.4k
Yan Xu China 36 1.7k 0.7× 1.8k 1.1× 1.8k 1.2× 742 0.8× 553 0.6× 432 5.9k
Xiaoming Liu China 46 4.3k 1.8× 1.6k 1.0× 841 0.6× 1.1k 1.2× 1.1k 1.2× 276 8.2k
Qi Zhang China 42 2.7k 1.1× 969 0.6× 979 0.6× 1.2k 1.3× 1.0k 1.1× 371 6.5k
Mengyuan Li China 32 1.9k 0.8× 789 0.5× 1.1k 0.7× 799 0.8× 953 1.0× 219 5.5k
Jeanine D’Armiento United States 53 3.5k 1.4× 2.1k 1.3× 1.1k 0.8× 1.6k 1.7× 811 0.9× 140 8.6k
Jun Jiang China 37 1.6k 0.7× 758 0.5× 1.3k 0.9× 1.1k 1.2× 644 0.7× 331 5.2k
Weichang Chen China 35 2.0k 0.8× 500 0.3× 1.0k 0.7× 1.0k 1.1× 860 0.9× 210 4.4k
Rong Yin China 39 3.6k 1.5× 1.1k 0.6× 1.4k 0.9× 3.0k 3.1× 572 0.6× 211 6.2k
Yuanlin Song China 35 2.5k 1.0× 1.9k 1.2× 583 0.4× 491 0.5× 729 0.8× 130 5.6k

Countries citing papers authored by Peng Zhang

Since Specialization
Citations

This map shows the geographic impact of Peng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhang more than expected).

Fields of papers citing papers by Peng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhang. The network helps show where Peng Zhang may publish in the future.

Co-authorship network of co-authors of Peng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zhang. A scholar is included among the top collaborators of Peng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zhang. Peng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jia, Xutao Zhang, Xinyan Li, et al.. (2025). TRAF7 protects against acute lung injury by promoting K6-linked ubiquitination of AKT. Science Bulletin. 71(3). 510–514.
2.
Jiang, Cong, Qiangsheng Hu, Shuqi Wang, et al.. (2025). Tumor microenvironment-responsive engineered hybrid nanomedicine for photodynamic-immunotherapy via multi-pronged amplification of reactive oxygen species. Nature Communications. 16(1). 424–424. 31 indexed citations breakdown →
3.
Shen, Ziyun, Lele Zhang, Huansha Yu, et al.. (2024). Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma. The Annals of Thoracic Surgery. 118(2). 385–393. 5 indexed citations
5.
Zhang, Peng, et al.. (2023). Disease burden of COPD in the Chinese population: a systematic review. Therapeutic Advances in Respiratory Disease. 17. 2683798227–2683798227. 12 indexed citations
6.
Jiang, Cong, Xianglong Li, Fen Pan, et al.. (2023). Ferroptosis and Pyroptosis Co‐Activated Nanomodulator for “Cold” Tumor Immunotherapy and Lung Metastasis Inhibition. Advanced Functional Materials. 33(37). 35 indexed citations
7.
Liu, Meiyun, Peng Zhang, Suyu Wang, Wei Guo, & Yibin Guo. (2023). Comparation between novel online models and the AJCC 8th TNM staging system in predicting cancer-specific and overall survival of small cell lung cancer. Frontiers in Endocrinology. 14. 1132915–1132915. 3 indexed citations
8.
Zhang, Peng, et al.. (2023). Dioscin ameliorates silica-aggravated systemic lupus erythematosus via suppressing apoptosis and improving LC3-associated phagocytosis in MRL/lpr mice. International Immunopharmacology. 116. 109814–109814. 3 indexed citations
9.
Dai, Jie, Xiaogang Liu, Yang Yang, et al.. (2023). Surgery for bronchiectasis-destroyed lung: feasibility of video-assisted thoracoscopic surgery, and surgical outcomes. Interdisciplinary CardioVascular and Thoracic Surgery. 38(2).
10.
Zhu, Xianmin, Yuehua Gao, Yixiao Dong, et al.. (2023). DNA methylation in small cell lung cancer. SHILAP Revista de lepidopterología. 3(3).
11.
Zhang, Peng, et al.. (2021). Efficacy of Two-Stage Meek Micrografting in Patients With Severe Burns. Journal of Burn Care & Research. 43(5). 1081–1085. 1 indexed citations
12.
Li, Chenhui, Lele Zhang, Hai Hu, et al.. (2021). RNF111-facilitated neddylation potentiates cGAS-mediated antiviral innate immune response. PLoS Pathogens. 17(3). e1009401–e1009401. 37 indexed citations
13.
Sun, Dongqing, Jin Wang, Ya Han, et al.. (2020). TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Research. 49(D1). D1420–D1430. 689 indexed citations breakdown →
14.
Shi, Sailing, Shengqing Gu, Wubing Zhang, et al.. (2020). Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors. Clinical Cancer Research. 26(22). 5990–6002. 45 indexed citations
15.
Liu, Ningning, Qiang Ma, Yang Ge, et al.. (2020). Microbiome dysbiosis in lung cancer: from composition to therapy. npj Precision Oncology. 4(1). 33–33. 103 indexed citations
16.
Sun, Mengyao, Ye Guo, Guoguang Shao, et al.. (2019). Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational Cancer Research. 8(7). 2581–2592. 2 indexed citations
17.
Yang, Jie, Bo Wang, Aaron M. Gusdon, et al.. (2019). The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis. Clinical & Experimental Metastasis. 36(5). 457–466. 23 indexed citations
18.
Sun, Mengyao, Ye Guo, Guoguang Shao, et al.. (2019). Analysis of real-word mutations of lung cancer driver genes in five regions of China. Translational Cancer Research. 8(7). 2581–2592. 3 indexed citations
19.
Dong, Liang, Jingwen Xia, Jing Zhang, et al.. (2018). Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report. BMC Pulmonary Medicine. 18(1). 13–13. 5 indexed citations
20.
Shuai, Xiaoming, Jinbo Gao, Xinghua Liu, et al.. (2016). Clinical efficacy of neoadjuvant chemotherapy combined with laparoscopy-assisted radical gastrectomy for advanced gastric cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 15(3). 241–246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026